Genetic Engineering and Biotechnology News (GEN) Wins 2011 Folio B2B Best Online News Coverage Award

Nov. 9, 2011 - PRLog -- New Rochelle, NY—GEN (http://www.genengnews.com) announced today that it is the proud winner of the Gold FOLIO 2011 Award for Best Online News Coverage in the B2B sector. Folio:magazine (http://www.foliomag.com/2011/2011-folio-award-winners-announced) sponsors the award competition, the largest in the publishing industry, honoring excellence in outstanding editorial and design.

This award affirms that GEN's comprehensive coverage of the biotech industry through a multichannel approach (print, digital and online) has been essential in driving its growth in addition to enabling meaningful, worldwide collaborations, according to Joan Boyce, Executive Director and Group Publisher, GEN.

“We are honored to have won this prestigious award. GEN continues to evolve to ensure our readers can engage with experts in the industry, while learning about cutting-edge technologies, platforms and tools that will enhance their productivity. Our multichannel publishing platform also provides a unique and action-oriented context for tool providers to interact with our readers and website visitors,” says Boyce.

“For over 30 years GEN has grown and expanded, moving from print-only to a multichannel publication with a robust online presence. It is with great pride that we accept this award and will continue to strive to provide content that best serves our readers,” says John Sterling, Editor in Chief, GEN.

“GEN is very proud and appreciative of this award and is totally committed to our mission to grow and support the biotechnology industry in the United States and around the globe,” adds Mary Ann Liebert, president and CEO of Mary Ann Liebert, Inc. (http://www.liebertpub.com)

# # #

Genetic Engineering & Biotechnology News (GEN, www.genengnews.com) has retained its position as the number one biotech publisher around the globe since its launch in 1981. GEN publishes a print edition 21 times a year and has additional exclusive editorial content online, such as news and analysis, podcasts, webinars, polls, videos, and application notes. GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocess.

Mary Ann Liebert, Inc. is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Assay & Drug Development Technologies, Human Gene Therapy and Tissue Engineering. A complete list of the firm’s 70 journals, books, and newsmagazines is available at our website (www.liebertpub.com).